Joseph Frank Oldakowski, CLOVER HEALTH INVESTMENTS, CORP. /DE’s VP of Finance and Controller, sold 20,000 shares at $5.16 each on September 14, 2026. The transaction represented about 6.7% of his prior holding, leaving him with 279,067 shares, a disclosed ownership figure investors can track.
Key Highlights
- The shares changed hands at $5.16 each on September 14, 2026.
- Joseph Frank Oldakowski held 279,067 shares after the transaction.
- The sale represented about 6.7% of his prior share holding.
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) finance executive Joseph Frank Oldakowski sold 20,000 shares. The filing reports the sale and states that Oldakowski owned 279,067 shares afterward.
Transaction Priced at $5.16 Per Share
The transaction took place on September 14, 2026, at $5.16 per share. The filing lists SEC transaction code S. The reported activity concerns Oldakowski’s shares in the company.
Insider Holding After the Sale
The transaction represented about 6.7% of Oldakowski’s prior share holding. His reported ownership after the sale was 279,067 shares. The filing states that the 6.7% figure represents the percentage of Oldakowski’s prior share holding and reports 279,067 shares after the transaction. Transaction code S denotes an open-market or private sale.
FAQs
Q: How many CLOV shares did Joseph Frank Oldakowski sell?
A: Joseph Frank Oldakowski sold 20,000 CLOVER HEALTH INVESTMENTS, CORP. /DE shares. The transaction was priced at $5.16 per share on September 14, 2026.
Q: What was the impact of the CLOV insider sale on ownership?
A: The transaction represented about 6.7% of Oldakowski’s prior share holding. After the sale, the filing reported that he owned 279,067 CLOVER HEALTH INVESTMENTS, CORP. /DE shares.
Q: What does the CLOV insider transaction mean for investors?
A: The filing reports that Oldakowski sold 20,000 shares at $5.16 per share under SEC transaction code S. It also reports that he owned 279,067 shares afterward.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.